7 Tips For Finding a Clinical Trial for Your Rare Disease
The world of Clinical Trials can be a mystery for many. The process can be cumbersome, and as we know, there are not always clinical trials going on in the wide range of rare diseases, making it sometimes frustrating and an emotional rollercoaster. Here are some pointers to get familiar with that will help you along your way toward finding the right clinical trial for you.
The most comprehensive source of clinical studies is clinicaltrials.gov
All new studies for therapies seeking FDA approval are listed on the FDA website clinicaltrials.gov, and can be searched by the disease.
Note the phase of the study
These are the stages of study for a new medication which is part of the approval process with the FDA.
Phase I studies are designed to study the safety of the medication. This may have only a few participants and may be with healthy volunteers.
Phase 2 studies are designed to see if the medication is effective. This is also a “proof” study, and the medication is given to people with the disease or condition.
Phase 3 studies have more participants to make sure the Phase 2 results are similar in a larger group of people with the condition or disease. It is usually the final phase before applying for approval from the FDA.
Phase IV studies, after the medication is approved by the FDA, continue to be studied over a longer period of time
3. Look at the type of study
Biomarker studies are studies looking at risk factors, signs of disease, or severity of disease.
Natural history studies: these studies show how the symptoms of a disease can change or progress over time.
Interventional studies: these are studies of medications, devices, or non-medical therapies that can be used to treat a condition or symptoms of that condition
4. Check the inclusion/exclusion criteria which specify the requirements to participate in the study
The inclusion criteria are the qualities a person must have to participate such as your diagnosis, how long you’ve been diagnosed, your age, symptoms, what medication you’re taking, and findings from your lab or blood tests (such as platelet or white blood cell levels, kidney and liver findings, genes or antibodies)
Exclusion criteria if you have these factors, you probably will not be able to participate in the study. This can include:
Medications you might be taking, or a recent change in medication
Other conditions you may have (such as heart disease, liver disease, etc.)
Procedures or surgeries you may have had, like plasmapheresis or thymectomy
5. Ask about travel assistance
If there is no study center location in your area, often the sponsor may reimburse you or pay for travel expenses or overnight stays in a hotel nearby. This is something you can ask the study team when you speak to them, or there may be an email address to contact if you are interested in learning more about the study.
6. You can get free access to a potential new treatment for your disease
Although there is no guarantee that the medication in development will be effective for you, if you do participate in a study and the medication seems to be working well for you, you may be able to continue receiving the medication free of cost for an extended period of time, until it’s approved by the FDA for use. (Note that different studies can have different extended use provisions).
Deciding whether to participate is not always an easy decision, but doing so can offer the potential to help not just you, but other individuals with the same condition in the future. Not every clinical trial results in an approved medication and many medications fail to meet their goals and are never approved.
7. Use Know Rare, which makes it easier to find a clinical study and talk to a researcher
The Know Rare Study Finder provides an easy search tool for all the clinical studies listed on clinicaltrials.gov. By filling out a short survey just once, you can be matched to a clinical study for a potential treatment for your disease or condition.
If you choose to apply to a study offering virtual pre-screening visits, you can schedule a live virtual ‘visit’ with a member of the study’s research team who can review all you need to know about the study and see if you are eligible to participate in it.
If you don’t meet the requirements for one study, it matches you to any others that are listed for your disease, and it is updated constantly, so even if there’s no study for you today, there may be one for you tomorrow.
To find a study for your disease or condition, contact us here.
Latest From Know Rare
In children, ITP is more often diagnosed during the fall and winter. This pattern suggests that infections or environmental factors, such as viruses or some vaccines, may trigger the immune system to attack platelets. Researchers wondered if the time of year also affected when adults develop ITP.
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
Las dificultades y la fortaleza de una familia a la hora de buscar respuestas y obtener un diagnóstico para su hijo, tras numerosas pruebas, biopsias cerebrales y hospitalizaciones. Y el alivio, pero también el dolor, al poder finalmente ponerle nombre a la enfermedad rara que afecta a su hijo: el trastorno relacionado con el gen BCL11B.
La Fundación Danon apoya decididamente a las personas que padecen la enfermedad de Danon, proporcionándoles información fiable, recursos y apoyo para ayudarles a afrontar la vida, desde el diagnóstico hasta el tratamiento.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
Si te han dicho que padeces NMOSD seronegativa, hay casi un 50 % de probabilidades de que sea otro anticuerpo el que provoque tus síntomas: el anticuerpo MOG.
Therapy Near Me es un servicio de salud mental de ámbito nacional con sede en Australia que facilita el acceso a psicólogos, terapeutas, especialistas en apoyo conductual y trabajadores sociales.
En la edición anual de la «Kidney Week» de la Sociedad Americana de Nefrólogos (ASN), la mayor organización mundial de profesionales sanitarios especializados en nefrología, se presentaron los últimos avances en investigación. Se han invertido más de 35 millones de dólares en investigación con la ASN, y hay numerosos tratamientos en fase de desarrollo para la nefropatía por IgA (IgAN), con investigadores que estudian activamente más de 20 fármacos diferentes.
Cuando me diagnosticaron la enfermedad celíaca, pensé que bastaría con evitar el pan y la pasta. Pronto me di cuenta de que llevar una vida verdaderamente sin gluten es mucho más complicado, y comparto mi experiencia para ayudar a las personas recién diagnosticadas a comprender lo que les espera.
La retinopatía es un problema ocular que padecen muchas personas con la enfermedad de Danon. Puede provocar manchas oscuras en la parte exterior del ojo, visión borrosa o empeoramiento de la visión, y resultados anormales en un examen oftalmológico. A veces, estos cambios oculares aparecen antes que los problemas cardíacos, por lo que un examen oftalmológico puede ayudar a detectar la enfermedad en una fase temprana.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. es una organización sin ánimo de lucro con sede en Florida, fundada en memoria de Kaya Humbert, una preciosa niña que nació con el síndrome de insuficiencia de esfingosina fosfato liasa (SPLIS), uno de los 46 casos conocidos en todo el mundo. La fundación se dedica a empoderar a las familias proporcionándoles información sobre su salud genética, así como a promover el acceso temprano a las pruebas genéticas y la sensibilización sobre las enfermedades raras.
Un poema en prosa de Jim Kuhn, un valiente luchador que vive con sarcoidosis, una enfermedad inflamatoria poco común.
Laura, de Rare Mom, nos cuenta cómo los preparativos de su familia para Halloween se convirtieron en una explosión de amor y creatividad familiar, ya que todos colaboraron en el diseño y la confección de un disfraz para Alden, su hijo con una enfermedad compleja.
En lugar de partir de un compuesto farmacológico recién descubierto, la investigación orientada al paciente (PCOR) es un tipo de investigación que comienza por dirigirse a los pacientes y a sus cuidadores y preguntarles: «¿Qué es lo que más les importa?», «¿Qué preguntas quieren que se respondan?», «¿Qué síntomas desearían que se controlaran mejor?» y «¿Qué les quita el sueño?».
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
¿Por qué nos cuesta tanto aceptar ayuda? A menudo, las personas asociamos la ayuda con la debilidad y la pérdida de independencia y control. Sin embargo, si cambiamos nuestra forma de pensar, aceptar ayuda puede considerarse una forma de empoderamiento: mostrar vulnerabilidad y confiar en alguien para que nos ayude requiere una gran fortaleza.
Tener una enfermedad rara supone una carga mental enorme. Rare Human Lindsay cuenta que hay cosas que ya no le importan, mientras se ocupa de los síntomas de su enfermedad rara, de los especialistas y de los ensayos clínicos.
Lindsay, de Rare Human, comparte sus «aspectos positivos». No se trata de que «lo que no te mata te hace más fuerte», sino de que lo que no te mata te hace más valiente. Nos cuenta que ha establecido vínculos más profundos con los demás, ha mejorado su capacidad para pedir y aceptar ayuda, y ya no le da tanto miedo la palabra «no».
La periodista y defensora de las enfermedades raras Lindsay Guentzel explica por qué los ensayos clínicos son un salvavidas para la comunidad de personas afectadas por enfermedades raras. Dado que solo el 5 % de las enfermedades raras conocidas cuenta con un tratamiento aprobado por la FDA, los ensayos suelen ser la única vía hacia el tratamiento, el progreso y la esperanza.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Nina Wachsman
Nina es cofundadora y presidenta de Know Rare
La experiencia de Nina abarca diversas áreas terapéuticas, desde enfermedades raras como la hipertensión arterial pulmonar (HAP) hasta enfermedades autoinmunes y el cáncer, y sus conocimientos se extienden desde la investigación de mercados y la estrategia hasta el marketing dirigido a pacientes y el marketing digital.
Además, ha sido fundadora e inversora ángel de una start-up biotecnológica, ha colaborado en la creación de la marca de una organización de pacientes oncológicos, Aim at Melanoma, y ha trabajado en la educación de los pacientes sobre Herceptin, el tratamiento líder de Genentech contra el HER2.
Nina es también madre, abuela, artista y autora de *La galería de las bellezas*, una novela ambientada en la Venecia de principios del siglo XVII.